Wall Street Experts
ver. ZuMIgo(08/25)
CureVac N.V.
Rachunek Zysków i Strat
Przychody TTM (mln): 543
EBIT TTM (mln): 132
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
Rok finansowy |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
13 |
17 |
49 |
103 |
67 |
53 |
535 |
Przychód Δ r/r |
0.0% |
35.3% |
180.8% |
110.6% |
-34.5% |
-21.9% |
916.4% |
Marża brutto |
-37.9% |
-60.7% |
71.0% |
-131.3% |
-172.9% |
-173.0% |
80.2% |
EBIT (mln) |
-73 |
-99 |
-124 |
-412 |
-249 |
-276 |
178 |
EBIT Δ r/r |
0.0% |
36.6% |
24.6% |
232.5% |
-39.5% |
10.7% |
-164.3% |
EBIT (%) |
-565.8% |
-571.3% |
-253.6% |
-400.3% |
-370.0% |
-524.6% |
33.2% |
Koszty finansowe (mln) |
0 |
1 |
22 |
10 |
4 |
2 |
0 |
EBITDA (mln) |
-67 |
-92 |
-110 |
-386 |
-223 |
-250 |
210 |
EBITDA(%) |
-521.1% |
-525.4% |
-224.5% |
-375.3% |
-330.9% |
-473.9% |
39.2% |
Podatek (mln) |
0 |
-0 |
-1 |
-1 |
-0 |
0 |
29 |
Zysk Netto (mln) |
-71 |
-100 |
-129 |
-412 |
-249 |
-255 |
162 |
Zysk netto Δ r/r |
0.0% |
40.2% |
29.2% |
219.0% |
-39.5% |
2.3% |
-163.6% |
Zysk netto (%) |
-553.5% |
-573.5% |
-264.0% |
-399.8% |
-369.4% |
-484.0% |
30.3% |
EPS |
-0.4 |
-0.53 |
-0.98 |
-2.21 |
-1.32 |
-1.15 |
0.7 |
EPS (rozwodnione) |
-0.4 |
-0.53 |
-0.98 |
-2.21 |
-1.32 |
-1.15 |
0.7 |
Ilośc akcji (mln) |
176 |
187 |
132 |
186 |
189 |
221 |
224 |
Ważona ilośc akcji (mln) |
176 |
187 |
132 |
186 |
189 |
221 |
225 |
Waluta |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |